Related Experiment Video
Updated: Oct 17, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Nutritional Status and Cognition in Older Adults: Modification by Apolipoprotein E ε4
Young Min Choe1,2, Ji-Hyun Kim1, Hye Ji Choi1
1Department of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, 7 Keunjaebong-gil, Hwaseong 18450, Gyeonggi, Republic of Korea.
Abstract:
Background: Malnutrition is a modifiable risk factor for late-life cognitive decline, but whether its cognitive correlates vary by genetic risk is unclear. We examined whether the apolipoprotein E ε4 allele (APOE4) modifies associations of the Mini-Nutritional Assessment (MNA) and its subscales with global cognition. Methods: In this cross-sectional analysis of 196 non-demented older Korean adults from the General Lifestyle and Alzheimer's Disease (GLAD) cohort, multiple linear regression tested associations of MNA total (MNA-T), screening (MNA-S), and assessment (MNA-A) scores with the CERAD total score (TS), including MNA × APOE4 interactions. Exploratory analyses examined one representative item per a priori nutritional domain. Results: After adjustment, MNA-T (p = 0.006) and MNA-A (p = 0.003), but not MNA-S (p = 0.065), were associated with TS. APOE4 carrier status modified these associations (interaction p = 0.005 and 0.007, respectively); associations were evident in non-carriers but not in carriers, an underpowered subgroup (n = 40). Among the domain-representative items, only self-rated health survived Bonferroni correction (p = 0.006); protein intake (p = 0.025) and calf circumference (p = 0.043) showed nominal associations only. Conclusions: Better nutritional status was associated with better global cognition, predominantly in APOE4 non-carriers. These hypothesis-generating findings require confirmation in larger longitudinal and interventional studies.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Alzheimer Disease ll: Pathophysiology
